ME

MEDIPOSTCO.,LTD.

Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.

078160 | KO

Overview

Corporate Details

ISIN(s):
KR7078160009
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDIPOST CO., LTD. is a global biotechnology company specializing in the development and commercialization of umbilical cord blood-derived stem cell therapeutics. The company focuses on regenerative medicine to address unmet medical needs. Its commercialized portfolio includes first-generation products such as CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. Alongside its therapeutic endeavors, MEDIPOST operates a significant private cord blood banking division for the collection and storage of stem cells. The company's research and development pipeline includes next-generation injectable and intravenous treatments for conditions like osteoarthritis (SMUP-IA-01) and diabetic nephropathy (SMUP-IV-01).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-09-01 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.4 KB
2025-08-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.5 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.9 MB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-28 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.6 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 36.3 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.1 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 735.7 KB
2025-03-17 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 1.4 MB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 1.4 MB

Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MEDIPOSTCO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France
BIM
BiomX Inc. Logo
Develops phage therapies to target harmful bacteria in chronic diseases like cystic fibrosis.
United States of America
PHGE
BioNTech SE Logo
Pioneering mRNA immunotherapies and vaccines to combat cancer and infectious diseases.
United States of America
BNTX
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark
BIOPOR
BioRestorative Therapies, Inc. Logo
A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.
United States of America
BRTX
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden
BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea
086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France
ALBIO
BIO-TECHNE Corp Logo
Develops reagents and instruments for life sciences research and clinical diagnostic markets.
United States of America
TECH
biote Corp. Logo
Trains practitioners in hormone optimization using bioidentical pellets and nutraceuticals.
United States of America
BTMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.